By actively reviewing literature published within Springer's own medical list as well as literature published elsewhere, SHC identifies articles that are relevant to pharmaceutical companies for bulk reprint sales.

What this means for pharmaceutical clients:

	SHC proactively searches on your behalf for articles that reinforce your product message
	SHC will regularly update product and publication managers through our global sales team with articles of interest for potential reprint sales
	SHC will work with you to negotiate bulk orders to support new product launches and development

This means that you can buy all your reprints from one source, whoever the publisher.

All reprints purchased through us have been copyright-cleared with the relevant copyright owner.

For further details, or if you would like to receive regular updates of books relevant to your area, please contact:

Elizabeth.Mclean@springer.com